11-66715854-G-A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_006946.4(SPTBN2):​c.285C>T​(p.Leu95Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0017 in 1,613,864 control chromosomes in the GnomAD database, including 43 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0088 ( 23 hom., cov: 32)
Exomes 𝑓: 0.00096 ( 20 hom. )

Consequence

SPTBN2
NM_006946.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.174

Publications

3 publications found
Variant links:
Genes affected
SPTBN2 (HGNC:11276): (spectrin beta, non-erythrocytic 2) Spectrins are principle components of a cell's membrane-cytoskeleton and are composed of two alpha and two beta spectrin subunits. The protein encoded by this gene (SPTBN2), is called spectrin beta non-erythrocytic 2 or beta-III spectrin. It is related to, but distinct from, the beta-II spectrin gene which is also known as spectrin beta non-erythrocytic 1 (SPTBN1). SPTBN2 regulates the glutamate signaling pathway by stabilizing the glutamate transporter EAAT4 at the surface of the plasma membrane. Mutations in this gene cause a form of spinocerebellar ataxia, SCA5, that is characterized by neurodegeneration, progressive locomotor incoordination, dysarthria, and uncoordinated eye movements. [provided by RefSeq, Dec 2009]
SPTBN2 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 5
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, ClinGen, G2P, Orphanet, Labcorp Genetics (formerly Invitae), Illumina
  • autosomal recessive spinocerebellar ataxia 14
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 11-66715854-G-A is Benign according to our data. Variant chr11-66715854-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 305599.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.174 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00881 (1339/152018) while in subpopulation AFR AF = 0.03 (1245/41444). AF 95% confidence interval is 0.0287. There are 23 homozygotes in GnomAd4. There are 612 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 23 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006946.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTBN2
NM_006946.4
MANE Select
c.285C>Tp.Leu95Leu
synonymous
Exon 4 of 38NP_008877.2O15020-1
SPTBN2
NM_001411025.1
c.306C>Tp.Leu102Leu
synonymous
Exon 2 of 36NP_001397954.1A0A087WYQ1
SPTBN2
NM_001437541.1
c.285C>Tp.Leu95Leu
synonymous
Exon 3 of 37NP_001424470.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTBN2
ENST00000533211.6
TSL:5 MANE Select
c.285C>Tp.Leu95Leu
synonymous
Exon 4 of 38ENSP00000432568.1O15020-1
SPTBN2
ENST00000309996.7
TSL:1
c.285C>Tp.Leu95Leu
synonymous
Exon 3 of 37ENSP00000311489.2O15020-1
SPTBN2
ENST00000617502.5
TSL:5
c.306C>Tp.Leu102Leu
synonymous
Exon 2 of 36ENSP00000482000.2A0A087WYQ1

Frequencies

GnomAD3 genomes
AF:
0.00880
AC:
1336
AN:
151900
Hom.:
23
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0301
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00445
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00765
GnomAD2 exomes
AF:
0.00249
AC:
624
AN:
250928
AF XY:
0.00167
show subpopulations
Gnomad AFR exome
AF:
0.0326
Gnomad AMR exome
AF:
0.00217
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000123
Gnomad OTH exome
AF:
0.000816
GnomAD4 exome
AF:
0.000956
AC:
1398
AN:
1461846
Hom.:
20
Cov.:
34
AF XY:
0.000799
AC XY:
581
AN XY:
727220
show subpopulations
African (AFR)
AF:
0.0321
AC:
1074
AN:
33478
American (AMR)
AF:
0.00219
AC:
98
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000928
AC:
8
AN:
86246
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53410
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000764
AC:
85
AN:
1111998
Other (OTH)
AF:
0.00209
AC:
126
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
87
173
260
346
433
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00881
AC:
1339
AN:
152018
Hom.:
23
Cov.:
32
AF XY:
0.00824
AC XY:
612
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.0300
AC:
1245
AN:
41444
American (AMR)
AF:
0.00445
AC:
68
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5156
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4788
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10570
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
67978
Other (OTH)
AF:
0.00757
AC:
16
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
57
114
172
229
286
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00296
Hom.:
4
Bravo
AF:
0.0112
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
Autosomal dominant cerebellar ataxia (1)
-
-
1
Spinocerebellar ataxia type 5 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
5.7
DANN
Benign
0.84
PhyloP100
-0.17
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34117933; hg19: chr11-66483325; COSMIC: COSV59448289; COSMIC: COSV59448289; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.